[ Price : $8.95]
FDA Oncology Center of Excellence staff outlines steps to promote greater use of real-world evidence in cancer trials.[ Price : $8.95]
Washington Legal Foundation chief counsel Richard Samp criticizes a Third Circuit Court of Appeals decision in a Lipitor patent se...[ Price : $8.95]
A U.S. Chamber report outlines steps, including by FDA, that can be taken to restrict lawsuit advertising that it says can harm pu...[ Price : $8.95]
FDA clears a RadiaDyne 510(k) for two new indications for its OARtrac radiation dose monitoring platform.[ Price : $8.95]
FDA commissioner Scott Gottlieb outlines the agencys efforts as part of HHS to address the nations opioid crisis.[ Price : $8.95]
FDA sends PTC Therapeutics a complete response letter for its NDA for ataluren for treating nonsense mutation dystrophinopathies.[ Price : $8.95]
FDA issues Antares Pharma a complete response letter on its NDA for Xyosted (testosterone enanthate) injection for testosterone re...[ Price : $8.95]
Federal Register notice: FDA determines that HRA Pharmas Ovrette (norgestrel) tablets, 0.075 mg, was not withdrawn from sale for r...